Adam Fisher

Adam Fisher, PhD, serves on the Smith School Advisory Council in his personal capacity. Professionally, he is the Director of Enterprise Project Staff for the Office of Pharmaceutical Quality in the Center for Drug Evaluation and Research at the U.S. FDA. Adam focuses on engaging FDA stakeholders on drug quality and manufacturing and supporting the adoption of advanced pharmaceutical manufacturing technologies. At the FDA, he has served as a primary and secondary reviewer of generic drug applications and Drug Master Files, a subject matter expert on complex drug substances and advanced biomanufacturing, and a liaison to the United States Pharmacopeia BIO1 Expert Committee. He joined the FDA in 2014 as a chemical engineer and expert in the synthesis of biomolecules. Prior, he was co-founder and chief science officer of a biotechnology startup, Glycobia, Inc. He earned his BS in chemical engineering at the University of Maryland College Park and his PhD at the Smith School.